Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 11, 2024 OWNERSHIP DOCUMENT
4 Jun 11, 2024 4
4 Jun 11, 2024 4
4 Jun 11, 2024 4
4 Jun 11, 2024 4
4 Jun 11, 2024 4
4 Jun 11, 2024 4
4 Jun 11, 2024 4
S-8 Jun 10, 2024 S-8
8-K Jun 10, 2024 8-K
8-K Jun 7, 2024 8-K
8-K May 31, 2024 8-K
10-Q May 9, 2024 10-Q
8-K May 9, 2024 8-K
8-K May 9, 2024 8-K
424B3 May 2, 2024 424B3
EFFECT Apr 29, 2024
ARS Apr 26, 2024 ARS
DEFA14A Apr 26, 2024 DEFA14A
DEF 14A Apr 26, 2024 DEF 14A
CORRESP Apr 25, 2024
UPLOAD Apr 24, 2024
S-3 Apr 18, 2024 S-3
PRE 14A Apr 16, 2024 PRE 14A
4 Mar 25, 2024 OWNERSHIP DOCUMENT
← Newer Page 6 of 34 · 849 filings Older →